| (USD) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 173.91M | — |
| Operating expense | — | — |
| Net income | -18.55M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, TARS returned +27.0% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -11.2% |
| 1 year | +27.0% |
| 5 years | +174.3% |
| All-time high | $81.88 (Dec 2025) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in TARS would be worth today ›No. Tarsus Pharmaceuticals, Inc. has not paid a dividend in the past 12 months.
Tarsus Pharmaceuticals, Inc. stock trades on NASDAQ under the ticker symbol TARS.
Tarsus Pharmaceuticals, Inc. is part of the Healthcare sector.
Tarsus Pharmaceuticals, Inc. has a market cap of 3.19B USD, based on the latest quote.
Tarsus Pharmaceuticals, Inc. is expected to report earnings around Nov 4, 2026. That date is an estimate and has not been confirmed by the company.
